Edwards Lifesciences v Meril (CFI, 20 December 2024)
| Date | 20 December 2024 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Infringement Action |
| Registry reference | ACT_597277/2023 · ORD_598551/2023 |
| Parties | Edwards Lifesciences Corporation v. Meril GmbH, Meril Life Sciences Pvt. Ltd., Meril Italy S.r.l. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In an order of 20 December 2024 following the interim conference (UPC_CFI_501/2023), the Munich Local Division, acting through its judge-rapporteur, allowed Edwards Lifesciences to extend its infringement action on EP 3 669 828 to Romania and allowed the Meril companies to extend their counterclaim for revocation accordingly. More significantly, it held that the claimant’s specification of the information the defendants are to provide is not an amendment of the case under Rule 263 but falls under Rule 13. The order also set the value of the dispute at €16 million and organised the oral hearing of 11 February 2025.
Question
Do adding a country and specifying the content of a request for information require leave under Rule 263, and on what basis?
Decision
Not every new argument amounts to an amendment of the case: there is one only where the nature or scope of the dispute changes. Changes confined to how information is to be provided fall under Rule 13, read with recital 7 of the preamble requiring parties to present their case as early as possible. Having been filed well before the hearing, they were admitted, whether the information is actually owed being left open. As Romania was mentioned in neither the statement of claim nor the counterclaim, and both parties now wished to include it, leave was granted on both sides. The Division also invited the claimant to clarify the order in which its auxiliary requests to amend the patent, which split into two lines, should be considered, since the court cannot choose on the patentee’s behalf. Requests to hear party experts and to appoint a court expert were rejected for now.
Key points for practice
- A clarification filed well before the hearing may fall outside Rule 263 if it changes neither the nature nor the scope of the dispute.
- Auxiliary requests to amend arranged in parallel lines must be ranked by the patentee itself.
Provisions applied
- Rules of Procedure
- Rules 13, 105.5 and 263, recital 7 of the preamble
- Case law cited
- Court of Appeal, order of 21 November 2024, UPC_CoA_456/2024, Heraeus Electronics v Vibrantz, Munich Local Division, 2 December 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Patent infringement action.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantEdwards Lifesciences Corporation41 decisions in the corpusFollow this party
- defendantMeril GmbH45 decisions in the corpusFollow this party
- defendantMeril Life Sciences Pvt. Ltd.32 decisions in the corpusFollow this party
- defendantMeril Italy S.r.l.19 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- La précision des informations demandées aux défenderesses relève de la règle 13 et non de la règle 263, faute de modifier la nature ou l’étendue du litige. L’extension à la Roumanie de l’action et de la demande reconventionnelle est autorisée, les deux parties la souhaitant.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 669 828mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Edwards Lifesciences v Meril (CFI, 4 April 2025) cited in this record
- Edwards Lifesciences v Meril (CFI, 5 February 2025) cited in this record
- Heraeus Electronics v Vibrantz (CFI, 2 December 2024) cited in this record
- Edwards Lifesciences v Meril (CFI, 29 July 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 669 828Prosthetic heart valve recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 11 other decision(s): Edwards Lifesciences v Meril (CFI, 4 April 2025) · Edwards Lifesciences v Meril (CFI, 12 August 2026) · Edwards Lifesciences v Meril (CFI, 26 June 2026) · Edwards Lifesciences v Meril (CFI, 17 October 2025) · Edwards Lifesciences v Meril (CFI, 3 June 2025) · Edwards Lifesciences v Meril (CFI, 14 April 2025) · Edwards Lifesciences v Meril (CFI, ORD_60824/2024, 9 April 2025) · Edwards Lifesciences v Meril (CFI, 5 February 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.